TMCnet News

Research and Markets: Erectile Dysfunction Pipeline Review 2015 - 19 Companies & 22 Drug Profiles
[February 27, 2015]

Research and Markets: Erectile Dysfunction Pipeline Review 2015 - 19 Companies & 22 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/j2m4zl/erectile) has announced the addition of the "Erectile Dysfunction - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelins by identifying new targets and MOAs to produce first-in-class and best-in-class products.



Companies Involved in Therapeutics Development

  • Acorda Therapeutics, Inc.
  • Apricus Biosciences, Inc.
  • Aprogen, Inc.
  • Bioheart, Inc.
  • Biolab Sanus Farmaceutica Ltda.
  • Corridor Pharmaceuticals Inc.
  • Furiex Pharmaceuticals, Inc.
  • Futura Medical plc
  • Hanmi Pharmaceuticals, Co. Ltd.
  • IntelGenx Corp.
  • Mezzion Pharma Co. Ltd.
  • Mitsubishi (News - Alert) Tanabe Pharma Corporation
  • NAL Pharmaceuticals Ltd.
  • Pacific Therapeutics Ltd.
  • Palatin Technologies, Inc.
  • Pharmicell Co., Ltd.
  • Sagene Pharmaceuticals, Inc.
  • Suda Ltd
  • Yungjin Pharm Ind. Co., Ltd.

Drug Profiles


  • AdipoCell
  • alprostadil
  • AP-102
  • BL-214
  • cimaglermin alfa
  • dapoxetine hydrochloride
  • HCP-1302
  • HCP-1303
  • Immpocellgram
  • MED-2002
  • Next Generation Melanocortin Receptor IV Agonist
  • Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Erectile Dysfunction
  • PL-6983
  • selegiline + PDE-5 Inhibitor
  • sildenafil citrate
  • Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction
  • T-6932
  • tadalafil
  • tadalafil
  • TPN-729
  • udenafil
  • YBH-1603

For more information visit http://www.researchandmarkets.com/research/j2m4zl/erectile


[ Back To TMCnet.com's Homepage ]